THU0503 Anti-C1Q Antibody as Marker of Renal Involvement in Childhood-Onset Systemic Lupus Erythematosus

2015 ◽  
Vol 74 (Suppl 2) ◽  
pp. 382.1-382
Author(s):  
C. Picard ◽  
N. Fabien ◽  
B. Ranchin ◽  
P. Cochat ◽  
A. Belot
2017 ◽  
Vol 32 (9) ◽  
pp. 1537-1545 ◽  
Author(s):  
Cécile Picard ◽  
Jean-Christophe Lega ◽  
Bruno Ranchin ◽  
Pierre Cochat ◽  
Natalia Cabrera ◽  
...  

2010 ◽  
Vol 32 (1) ◽  
pp. 47-51 ◽  
Author(s):  
Samia Salah-El-Din Mahmoud ◽  
Hafez Mahmoud Bazaraa ◽  
Hala Mohamed Lotfy ◽  
Doaa Mohamed Abd-El-Aziz

F1000Research ◽  
2015 ◽  
Vol 4 ◽  
pp. 128
Author(s):  
Dawn M. Wahezi

Renal involvement occurs in 50-75% of children with childhood-onset systemic lupus erythematosus (cSLE). Proliferative lupus nephritis (LN) represents the most common pattern of renal involvement in cSLE. Despite aggressive treatment, progression to end stage renal disease can occur in up to 5-10% of children. Over the last 2 decades, tremendous advancements have been made in the treatment of pediatric LN. Special considerations in children need to address the impact of disease and therapy on both physical and psychological growth and development. This review will focus on pivotal clinical trials in the treatment of proliferative LN, with a focus on pediatric data when available.


Lupus ◽  
2020 ◽  
pp. 096120332097277
Author(s):  
Kamal El-Garf ◽  
Ayman El-Garf ◽  
Rasha Gheith ◽  
Shaimaa Badran ◽  
Samia Salah ◽  
...  

Introduction Disease features and laboratory abnormalities differ among adult-onset and childhood-onset systemic lupus erythematosus (aSLE and cSLE). Socioeconomic status both independent of, and in combination with, ethnicity influences the disease phenotype and outcome. Objective To compare the various disease features among patients with cSLE and aSLE in a limited monetary income Egyptian cohort attending a large free-of-charge university hospital. Patients and methods: Retrospective analysis of the medical records of 714 SLE patients attending Cairo University Hospitals from January 2000 to December 2019. Of them 602 (400 with aSLE and 202 with cSLE) were enrolled in the study. Results The mean age of disease onset was 28.27 ± 10.55 among aSLE patients compared to 12.88 ± 4.26 years among cSLE patients. Disease duration was 12.03 ± 5.05 and 4.14 ± 3.18 years in aSLE and cSLE, respectively. Female to male ratio was 15:1 among patients with aSLE, as compared to 2.67:1 among cSLE (<0.001). Arthritis (69%), oral ulcers (48.5%), neuropsychiatric (18.3%) and thrombotic manifestations of antiphospholipid syndrome (12%) were significantly more frequent in aSLE. On the other hand, renal (67.8%), serositis (49.6%), fever (49%), lymphopenia (40.6%), hemolytic anemia (38.6%), and discoid lupus (13.4%) were significantly more frequent in cSLE. Weight loss, malar rash, photosensitivity, thrombocytopenia, leucopenia and lymphadenopathy were not significantly different between the two groups. Hypocomplementemia, proteinuria, urinary sediments, hematuria were significantly more frequent in cSLE. For those patients with renal involvement, who underwent renal biopsy (58.3% in aSLE and 63.5% in cSLE), there was no significant difference with regard to the different histopathological classes. Anti-Smith, anti-cardiolipin antibodies and rheumatoid factor were significantly more frequent among aSLE patients, while anti-La antibodies were more frequent among cSLE patients. Conclusion Arthritis was the most common clinical manifestation over time in aSLE compared to renal involvement in cSLE. Renal disease tends to be more active in cSLE. The differences in disease manifestations between this cohort and other studies can be attributed to the ethnic and socioeconomic disparities.


2021 ◽  
Author(s):  
Vitor Cavalcanti Trindade ◽  
Magda Carneiro-Sampaio ◽  
Eloisa Bonfa ◽  
Clovis Artur Silva

Sign in / Sign up

Export Citation Format

Share Document